aTranslational Addiction Research Laboratory, Centre for Addiction and Mental Health, University of Toronto, Ontario, Canada
bDepartment of Neuroscience, Pasteur Institute, Paris, France
cNational Institute on Drug Abuse, Intramural Research Program, Baltimore, USA
dAcute Care Program
eCampbell Family Mental Health Research Institute, Centre for Addiction and Mental Health
fDepartment of Family and Community Medicine
gDepartment of Pharmacology and Toxicology
hDepartment of Psychiatry, Division of Brain and Therapeutics
iInstitute of Medical Sciences, University of Toronto, Toronto, Ontario, Canada
Received 28 April 2020 Accepted as revised 6 October 2020
Correspondence to Dr Bernard Le Foll, Centre for Addiction and Mental Health, 33 Ursula Franklin Street, Toronto, Ontario, M5S 2S1, Canada, Tel: +1 416 535 8501; e-mail: [email protected]